Annual Short Term Debt
$4.10 M
+$2.38 M+138.42%
01 December 2023
Summary:
Plus Therapeutics annual short term debt is currently $4.10 million, with the most recent change of +$2.38 million (+138.42%) on 01 December 2023. During the last 3 years, it has fallen by -$2.37 million (-36.67%). PSTV annual short term debt is now -71.16% below its all-time high of $14.20 million, reached on 31 December 2018.PSTV Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$3.36 M
-$24.00 K-0.71%
01 September 2024
Summary:
Plus Therapeutics quarterly short term debt is currently $3.36 million, with the most recent change of -$24.00 thousand (-0.71%) on 01 September 2024. Over the past year, it has dropped by -$736.00 thousand (-17.97%). PSTV quarterly short term debt is now -77.71% below its all-time high of $15.07 million, reached on 31 March 2019.PSTV Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -18.0% |
| 3 y3 years | -36.7% | -51.0% |
| 5 y5 years | -71.2% | -69.7% |
PSTV Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -36.7% | +138.4% | -51.0% | +96.3% |
| 5 y | 5 years | -71.2% | +138.4% | -70.3% | +96.3% |
| alltime | all time | -71.2% | +3461.7% | -77.7% | >+9999.0% |
Plus Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.36 M(-0.7%) |
| June 2024 | - | $3.38 M(-8.7%) |
| Mar 2024 | - | $3.71 M(-9.5%) |
| Dec 2023 | $4.10 M(+138.4%) | $4.10 M(-8.3%) |
| Sept 2023 | - | $4.46 M(-7.3%) |
| June 2023 | - | $4.82 M(-6.7%) |
| Mar 2023 | - | $5.16 M(+200.6%) |
| Dec 2022 | $1.72 M(-0.1%) | $1.72 M(+0.2%) |
| Sept 2022 | - | $1.72 M(+0.2%) |
| June 2022 | - | $1.71 M(-0.3%) |
| Mar 2022 | - | $1.72 M(-0.1%) |
| Dec 2021 | $1.72 M(-73.4%) | $1.72 M(-74.9%) |
| Sept 2021 | - | $6.86 M(+1.7%) |
| June 2021 | - | $6.75 M(+2.2%) |
| Mar 2021 | - | $6.60 M(+2.0%) |
| Dec 2020 | $6.47 M(-42.9%) | $6.47 M(+2.3%) |
| Sept 2020 | - | $6.32 M(+2.5%) |
| June 2020 | - | $6.17 M(-45.5%) |
| Mar 2020 | - | $11.32 M(-0.1%) |
| Dec 2019 | $11.33 M(-20.2%) | $11.33 M(+2.1%) |
| Sept 2019 | - | $11.09 M(+1.1%) |
| June 2019 | - | $10.97 M(-27.2%) |
| Mar 2019 | - | $15.07 M(+6.1%) |
| Dec 2018 | $14.20 M(+4.2%) | $14.20 M(+1.4%) |
| Sept 2018 | - | $14.01 M(+1.2%) |
| June 2018 | - | $13.84 M(+0.8%) |
| Mar 2018 | - | $13.73 M(+0.8%) |
| Dec 2017 | $13.62 M(+105.5%) | $13.62 M(+0.9%) |
| Sept 2017 | - | $13.50 M(+100.1%) |
| June 2017 | - | $6.74 M(+0.9%) |
| Mar 2017 | - | $6.69 M(+0.9%) |
| Dec 2016 | $6.63 M(-10.0%) | $6.63 M(+25.9%) |
| Sept 2016 | - | $5.27 M(+50.7%) |
| June 2016 | - | $3.49 M(+102.7%) |
| Mar 2016 | - | $1.72 M(+19.2%) |
| Sept 2015 | - | $1.45 M(+5461.5%) |
| June 2015 | - | $26.00 K(-99.7%) |
| Mar 2015 | - | $10.00 M(+35.8%) |
| Dec 2014 | $7.36 M(+130.7%) | $7.36 M(+34.4%) |
| Sept 2014 | - | $5.48 M(-25.4%) |
| June 2014 | - | $7.34 M(+40.1%) |
| Mar 2014 | - | $5.24 M(+64.2%) |
| Dec 2013 | $3.19 M(-67.4%) | $3.19 M(+167.5%) |
| Sept 2013 | - | $1.19 M(+5581.0%) |
| June 2013 | - | $21.00 K(-99.8%) |
| Mar 2013 | - | $9.80 M(+0.2%) |
| Dec 2012 | $9.78 M | $9.78 M(+0.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $9.77 M(+33.1%) |
| June 2012 | - | $7.34 M(+49.4%) |
| Mar 2012 | - | $4.91 M(+97.5%) |
| Dec 2011 | $2.49 M(-61.5%) | $2.49 M(+3504.3%) |
| Sept 2011 | - | $69.00 K(-99.2%) |
| June 2011 | - | $8.76 M(+0.4%) |
| Mar 2011 | - | $8.72 M(+35.2%) |
| Dec 2010 | $6.45 M(+138.6%) | $6.45 M(+53.2%) |
| Sept 2010 | - | $4.21 M(+112.9%) |
| June 2010 | - | $1.98 M(-28.8%) |
| Mar 2010 | - | $2.78 M(+2.7%) |
| Dec 2009 | $2.71 M(+32.1%) | $2.71 M(+2.7%) |
| Sept 2009 | - | $2.63 M(+2.7%) |
| June 2009 | - | $2.56 M(+2.7%) |
| Mar 2009 | - | $2.50 M(+22.0%) |
| Dec 2008 | $2.05 M(+183.9%) | $2.05 M(+453.2%) |
| Sept 2008 | - | $370.00 K(-23.4%) |
| June 2008 | - | $483.00 K(-19.6%) |
| Mar 2008 | - | $601.00 K(-16.6%) |
| Dec 2007 | $721.00 K(-27.8%) | $721.00 K(+4.2%) |
| Sept 2007 | - | $692.00 K(-10.2%) |
| June 2007 | - | $771.00 K(-18.8%) |
| Mar 2007 | - | $949.00 K(-5.0%) |
| Dec 2006 | $999.00 K(+4.9%) | $999.00 K(+12.8%) |
| Sept 2006 | - | $886.00 K(-4.5%) |
| June 2006 | - | $928.00 K(-3.3%) |
| Mar 2006 | - | $960.00 K(+0.8%) |
| Dec 2005 | $952.00 K(+1.5%) | $952.00 K(+38.2%) |
| Sept 2005 | - | $689.00 K(-10.9%) |
| June 2005 | - | $773.00 K(-9.7%) |
| Mar 2005 | - | $856.00 K(-8.7%) |
| Dec 2004 | $938.00 K(+30.8%) | $938.00 K(-2.1%) |
| Sept 2004 | - | $958.00 K(+8.1%) |
| June 2004 | - | $886.00 K(+4.6%) |
| Mar 2004 | - | $847.00 K(+18.1%) |
| Dec 2003 | $717.00 K(+74.9%) | $717.00 K(+26.7%) |
| Sept 2003 | - | $566.00 K(+32.9%) |
| June 2003 | - | $426.00 K(+2.2%) |
| Mar 2003 | - | $417.00 K(+1.7%) |
| Dec 2002 | $410.00 K(-39.3%) | $410.00 K(-60.9%) |
| Sept 2002 | - | $1.05 M(+51.0%) |
| June 2002 | - | $694.00 K(+1.6%) |
| Mar 2002 | - | $683.00 K(+1.0%) |
| Dec 2001 | $676.00 K(+487.8%) | $676.00 K(+487.8%) |
| Sept 2001 | - | $115.00 K(-0.9%) |
| June 2001 | - | $116.00 K |
| Dec 2000 | $115.00 K | - |
FAQ
- What is Plus Therapeutics annual short term debt?
- What is the all time high annual short term debt for Plus Therapeutics?
- What is Plus Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Plus Therapeutics?
- What is Plus Therapeutics quarterly short term debt year-on-year change?
What is Plus Therapeutics annual short term debt?
The current annual short term debt of PSTV is $4.10 M
What is the all time high annual short term debt for Plus Therapeutics?
Plus Therapeutics all-time high annual short term debt is $14.20 M
What is Plus Therapeutics quarterly short term debt?
The current quarterly short term debt of PSTV is $3.36 M
What is the all time high quarterly short term debt for Plus Therapeutics?
Plus Therapeutics all-time high quarterly short term debt is $15.07 M
What is Plus Therapeutics quarterly short term debt year-on-year change?
Over the past year, PSTV quarterly short term debt has changed by -$736.00 K (-17.97%)